These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17185821)

  • 1. Mechanical stimulation in vivo reduces osteocyte expression of sclerostin.
    Robling AG; Bellido T; Turner CH
    J Musculoskelet Neuronal Interact; 2006; 6(4):354. PubMed ID: 17185821
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteocytes and WNT: the mechanical control of bone formation.
    Galli C; Passeri G; Macaluso GM
    J Dent Res; 2010 Apr; 89(4):331-43. PubMed ID: 20200416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
    Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
    J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
    van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
    Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
    Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
    Bellido T
    J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression.
    Mabilleau G; Mieczkowska A; Edmonds ME
    Diabet Med; 2010 Aug; 27(8):925-32. PubMed ID: 20653751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.
    Tatsumi S; Ishii K; Amizuka N; Li M; Kobayashi T; Kohno K; Ito M; Takeshita S; Ikeda K
    Cell Metab; 2007 Jun; 5(6):464-75. PubMed ID: 17550781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanotransduction via estrogen receptors in bone].
    Imai Y; Kondoh S; Kato S
    Clin Calcium; 2008 Sep; 18(9):1272-7. PubMed ID: 18758032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocyte Mechanobiology.
    Uda Y; Azab E; Sun N; Shi C; Pajevic PD
    Curr Osteoporos Rep; 2017 Aug; 15(4):318-325. PubMed ID: 28612339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin, an osteocytes-derived bone-forming inhibitor.
    Włodarski KH; Galus R; Brodzikowska A; Włodarski PK
    Pol Orthop Traumatol; 2013 Jul; 78():151-4. PubMed ID: 23820854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading.
    Imai S; Heino TJ; Hienola A; Kurata K; Büki K; Matsusue Y; Väänänen HK; Rauvala H
    Bone; 2009 May; 44(5):785-94. PubMed ID: 19442624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative regional associations between remodeling, modeling, and osteocyte apoptosis and density in rabbit tibial midshafts.
    Hedgecock NL; Hadi T; Chen AA; Curtiss SB; Martin RB; Hazelwood SJ
    Bone; 2007 Mar; 40(3):627-37. PubMed ID: 17157571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein.
    Gould NR; Williams KM; Joca HC; Torre OM; Lyons JS; Leser JM; Srikanth MP; Hughes M; Khairallah RJ; Feldman RA; Ward CW; Stains JP
    Elife; 2021 Mar; 10():. PubMed ID: 33779549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocyte morphology in fibula and calvaria --- is there a role for mechanosensing?
    Vatsa A; Breuls RG; Semeins CM; Salmon PL; Smit TH; Klein-Nulend J
    Bone; 2008 Sep; 43(3):452-8. PubMed ID: 18625577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Osteocyte Mechanotransduction: Recent Developments and Future Directions.
    Hinton PV; Rackard SM; Kennedy OD
    Curr Osteoporos Rep; 2018 Dec; 16(6):746-753. PubMed ID: 30406580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mechanotransduction in porcine explants alters kinase activation and enhances trabecular bone formation in the absence of osteocyte signaling.
    Curtis KJ; Coughlin TR; Mason DE; Boerckel JD; Niebur GL
    Bone; 2018 Feb; 107():78-87. PubMed ID: 29154967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocytes: central conductors of bone biology in normal and pathological conditions.
    Neve A; Corrado A; Cantatore FP
    Acta Physiol (Oxf); 2012 Mar; 204(3):317-30. PubMed ID: 22099166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
    Appel H; Ruiz-Heiland G; Listing J; Zwerina J; Herrmann M; Mueller R; Haibel H; Baraliakos X; Hempfing A; Rudwaleit M; Sieper J; Schett G
    Arthritis Rheum; 2009 Nov; 60(11):3257-62. PubMed ID: 19877044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The osteocyte lineage.
    Noble BS
    Arch Biochem Biophys; 2008 May; 473(2):106-11. PubMed ID: 18424256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.